New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
07:05 EDTFMIFoundation Medicine says new clinical data to be presented at ASCO
Foundation Medicine announced new data demonstrating that FoundationOne identified actionable genomic alterations in a broad range of pediatric cancers. These data will be presented today in a poster highlights presentation at the 2014 American Society of Clinical Oncology Annual Meeting, abstract number 10035. Fully informative genomic profiling was conducted using FoundationOne on 400 pediatric tumors from patients 21 years old or younger at the time of sample procurement. Genomic alterations were identified in a majority of 326 unselected pediatric cancer clinical cases, and 241 of these patients were found to have at least one alteration targeted by an approved therapy or investigational therapy in clinical trials. These results suggest that routine use of accurate, comprehensive genomic profiling with FoundationOne or FoundationOne Heme in pediatric patients may inform treatment options.
News For FMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2015
16:34 EDTFMIThird Rock Ventures reports 2.4% stake in Foundation Medicine
Subscribe for More Information
April 20, 2015
08:32 EDTFMIFoundation Medicine appoints Timothy Dec as interim CFO
OpGen announced the expansion of its executive management team with the appointments of former Foundation Medicine executive Kevin Krenitsky as president, and Timothy C. Dec as interim CFO. Dec has more than 20 years of public company financial leadership experience in technology and healthcare, and will be charged with ensuring a smooth transition for OpGen from private to public company status and with public company reporting responsibilities.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use